Notice: Global Information Announces Listing on JASDAQ Standard Market of the Tokyo Stock Exchange

Cover Image
Market Research Report

Fertility Test Market by Product (Ovulation Predictor Kits, Fertility Monitors (Urine, Saliva, Blood)), Mode of Purchase (OTC, Prescription, Online), Application (Female, Male), End User (Home care, Fertility clinics, hospitals)- Global Forecast to 2025

Published by MarketsandMarkets Product code 998826
Published Content info 178 Pages
Delivery time: 1-2 business days
Price
Back to Top
Fertility Test Market by Product (Ovulation Predictor Kits, Fertility Monitors (Urine, Saliva, Blood)), Mode of Purchase (OTC, Prescription, Online), Application (Female, Male), End User (Home care, Fertility clinics, hospitals)- Global Forecast to 2025
Published: April 5, 2021 Content info: 178 Pages
Description

The fertility test market is projected to reach USD 680 Million by 2025 from USD 472 Million in 2020, at a CAGR of 7.5 % the forecast period. Growth in this market is primarily driven by by the increasing first-time pregnancy age in women, declining fertility rate among men and women, growing number of women suffering from disorders such as PCOS, emergence of advanced ovulation monitors, and the increased awareness of fertility testing in both developed as well as developing countries.

"In terms Purchase mode, OTC segment to register significant growth during the forecast period.."

Based on the mode of purchase, the fertility test market is segmented into direct/prescription, OTC, and online products. In 2020 the OTC segment had the major market share and exibited high growth. The high growth of this segment is attributed to the inclination of patients towards self-monitoring of healthcare conditions, increasing initiatives by market players to spread awareness on fertility, and the rising preference for confidentiality and accessibility of test results.

In terms Application, the female fertility testing segment is expected to account for the largest share of the fertility test market in 2020."

Based on the application, the fertility test market is segmented into female fertility testing and male fertility testing. In 2020, the female fertility testing segment accounted for a larger market share, primarily due to the decreasing female fertility rates, availability of a wide range of fertility testing options for females, increase in gynecological issues in women (such as PCOD/PCOS), and the high cost of IVF procedures.

"In terms of product segment, ovulation prediction kits segment is expected to account for the largest share during the forecast period."

Based on products, the fertility test market is segmented into ovulation prediction kits, fertility monitors & male fertility testing products. Large share is attributed to ovulation prediction kits segment due to the increasing use of ovulation prediction kits, easy over-the-counter availability and low cost, and higher accuracy than natural fertility testing techniques, such as calendar methods and cervical mucus monitoring.

"The home care settings segment is expected to register the highest CAGR during the forecast period" `

Based on end-users, the fertility test market has been segmented based on end-user category-home care settings, hospitals and fertility clinics, and other end users. The large share and high growth of this segment can be attributed to the inclination of patients toward self-monitoring of healthcare conditions, easy access to fertility and ovulation monitors on e-commerce websites, availability of user-friendly and easy-to-handle devices, and the growing preference for the confidentiality of test results.

"Asia Pacific market is expected to grow at the highest CAGR during the forecast period."

The Asia Pacific market is projected to register the highest CAGR during the forecast period. Growth in the Asia Pacific market is majorly due to the growing number of women suffering from lifestyle disorders, increasing funding/investments toward the development of fertility and ovulation monitors, and the growing focus of both international and domestic players on the Asia Pacific fertility test market.

A breakdown of the primary participants referred to for this report is provided below:

  • By Company Type: Tier 1-48%, Tier 2-36%, and Tier 3- 16%
  • By Designation: C-level-10%, Director-level-14%, and Others-76%
  • By Region: North America-40%, Europe-32%, Asia Pacific-20%, Latin America-5%, and the Middle East & Africa-3%

Swiss Precision Diagnostics (Switzerland), Church & Dwight (US), Prestige Brands Holdings (US), bioZhena (US), Fairhaven Health (US), Fertility Focus (UK), Geratherm Medical (Germany), Hilin Life Products (US), UEBE Medical (Germany), AdvaCare Pharma (US), AVA (Switzerland), Babystart (UK), Valley Electronics (Germany), Sensiia (UK), and Mira Care (US), among others are some of the major players operating in the global fertility test market.

Research Coverage

This report studies the fertility test market based on application, mode of purchase, by products, end user, and region. It studies significant factors (such as drivers and restraints) affecting market growth. The report also analyzes opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. It explains micro markets with respect to their growth trends, prospects, and contributions to the total market. The report forecasts the revenue of the market segments with respect to four major regions and their respective major countries.

Reasons to Buy the Report

The report will enable established firms as well as entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them to garner a larger market share. Firms purchasing the report could use one or a combination of the below-mentioned strategies for strengthening their market presence.

This report provides insights on the following pointers:

Market Penetration: Comprehensive information on the product portfolios offered by the top players in the fertility test market

Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product launches in the fertility test market

Market Development: Comprehensive information on lucrative emerging regions

Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the fertility test market

Competitive Assessment: In-depth assessment of market segments, growth strategies, revenue analysis, and products of the leading market players.

Table of Contents
Product Code: MD 4215

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
    • 1.2.1 INCLUSIONS AND EXCLUSIONS
  • 1.3 MARKET SCOPE
    • 1.3.1 MARKETS COVERED
    • 1.3.2 YEARS CONSIDERED FOR THE STUDY
  • 1.4 CURRENCY USED FOR THE STUDY
  • 1.5 STAKEHOLDERS
  • 1.6 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • FIGURE 1 RESEARCH DESIGN
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 Indicative list of secondary sources
    • 2.1.2 PRIMARY DATA
    • FIGURE 2 PRIMARY SOURCES
    • FIGURE 3 BREAKDOWN OF PRIMARIES: BY COMPANY TYPE, DESIGNATION, AND REGION
  • 2.2 MARKET ESTIMATION METHODOLOGY
    • FIGURE 4 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
    • 2.2.1 PRODUCT-BASED MARKET ESTIMATION
    • 2.2.2 VOLUME-BASED MARKET ESTIMATION
    • FIGURE 5 MARKET SIZE ESTIMATION: FERTILITY TEST MARKET
    • FIGURE 6 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
    • 2.2.3 PRIMARY RESEARCH VALIDATION
  • 2.3 DATA TRIANGULATION
    • FIGURE 7 DATA TRIANGULATION METHODOLOGY
  • 2.4 RESEARCH ASSUMPTIONS
  • 2.5 RESEARCH LIMITATIONS

3 EXECUTIVE SUMMARY

    • FIGURE 8 FERTILITY TEST MARKET, BY PRODUCT, 2020 VS. 2025 (USD MILLION)
    • FIGURE 9 FERTILITY TEST MARKET, BY MODE OF PURCHASE, 2020 VS. 2025 (USD MILLION)
    • FIGURE 10 FERTILITY TEST MARKET, BY APPLICATION, 2020 VS. 2025 (USD MILLION)
    • FIGURE 11 FERTILITY TEST MARKET, BY END USER, 2020 VS. 2025 (USD MILLION)
    • FIGURE 12 GEOGRAPHICAL SNAPSHOT OF THE FERTILITY TEST MARKET

4 PREMIUM INSIGHTS

  • 4.1 FERTILITY TEST MARKET OVERVIEW
    • FIGURE 13 INCREASING FIRST-TIME PREGNANCY AGE TO DRIVE MARKET GROWTH
  • 4.2 FERTILITY TEST MARKET, BY PRODUCT, 2020 VS. 2025 (USD MILLION)
    • FIGURE 14 OVULATION PREDICTION KITS SEGMENT TO DOMINATE THE MARKET IN 2025
  • 4.3 APAC FERTILITY TEST MARKET SHARE, BY COUNTRY AND APPLICATION (2020)
    • FIGURE 15 FEMALE FERTILITY TESTING SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE APAC FERTILITY TEST MARKET IN 2020
  • 4.4 FERTILITY TEST MARKET SHARE, BY END USER, 2020 VS. 2025
    • FIGURE 16 HOME CARE SETTINGS ARE THE LARGEST END USERS OF FERTILITY TESTING PRODUCTS
  • 4.5 FERTILITY TEST MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
    • FIGURE 17 CHINA TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • FIGURE 18 MARKET DYNAMICS: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
    • 5.2.1 DRIVERS
      • 5.2.1.1 Increasing first-time pregnancy age
      • 5.2.1.2 Declining fertility rates across the globe
    • FIGURE 19 DECLINE IN FERTILITY RATE IN THE US, 2008-2018
      • 5.2.1.3 Growing population of women of reproductive age
      • 5.2.1.4 Launch of advanced, easy-to-use fertility testing devices with high accuracy
      • 5.2.1.5 Increasing awareness of fertility testing
      • 5.2.1.6 Growing number of gynecological and reproductive issues in women and men
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 Lesser precision of ovulation prediction kits
      • 5.2.2.2 Unproven accuracy of urine-based ovulation monitors in PCOS/ PCOD patients
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Emergence of combined kits for dual testing of pregnancy and ovulation
      • 5.2.3.2 Emerging nations to offer new growth avenues
      • 5.2.3.3 Online sales of fertility testing devices
      • 5.2.3.4 High cost and low accuracy of IVF treatment
    • TABLE 1 COST OF IVF ACROSS VARIOUS COUNTRIES
    • 5.2.4 CHALLENGES
      • 5.2.4.1 High cost of fertility testing monitors
  • 5.3 ECOSYSTEM COVERAGE: PARENT MARKET (IN VITRO DIAGNOSTICS)
  • 5.4 REGULATORY ANALYSIS
    • 5.4.1 US
    • TABLE 2 US FDA: CLASSIFICATION OF IN VITRO DIAGNOSTIC DEVICES
    • FIGURE 20 US: REGULATORY PROCESS FOR IVD DEVICES
    • 5.4.2 CANADA
    • TABLE 3 CANADA: CLASSIFICATION OF IN VITRO DIAGNOSTIC DEVICES
    • FIGURE 21 CANADA: REGULATORY APPROVAL PROCESS FOR MEDICAL DEVICES
    • 5.4.3 EUROPE
    • TABLE 4 EUROPE: CLASSIFICATION OF IN VITRO DIAGNOSTIC DEVICES
    • FIGURE 22 EUROPE: REGULATORY PROCESS FOR IVD DEVICES
    • 5.4.4 JAPAN
    • TABLE 5 CLASSIFICATION OF IVD REAGENTS IN JAPAN
    • 5.4.5 CHINA
    • TABLE 6 CHINA: CLASSIFICATION OF MEDICAL DEVICES
    • TABLE 7 CHINA: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
    • 5.4.6 INDIA
    • FIGURE 23 INDIA: REGULATORY PROCESS FOR IVD DEVICES
  • 5.5 VALUE CHAIN ANALYSIS
  • 5.6 PRICING TREND ANALYSIS
    • TABLE 8 AVERAGE PRICE OF FERTILITY TESTING PRODUCTS, BY COUNTRY, 2020 (USD)
  • 5.7 PORTER'S FIVE FORCES ANALYSIS
    • 5.7.1 OVERVIEW
    • TABLE 9 FERTILITY TEST MARKET: PORTER'S FIVE FORCES ANALYSIS
    • 5.7.2 THREAT OF NEW ENTRANTS
    • FIGURE 24 THREAT OF NEW ENTRANTS
    • 5.7.3 THREAT OF SUBSTITUTES
    • FIGURE 25 THREAT OF SUBSTITUTES
    • 5.7.4 BARGAINING POWER OF SUPPLIERS
    • FIGURE 26 BARGAINING POWER OF SUPPLIERS
    • 5.7.5 BARGAINING POWER OF BUYERS
    • FIGURE 27 BARGAINING POWER OF BUYERS
    • 5.7.6 DEGREE OF COMPETITION
    • FIGURE 28 DEGREE OF COMPETITION
  • 5.8 NUMBER OF PATIENTS UTILIZING SPECIFIC FERTILITY TECHNIQUES WORLDWIDE (AS OF 2019)
    • TABLE 10 NUMBER OF PATIENTS UTILIZING SPECIFIC FERTILITY TECHNIQUES WORLDWIDE (AS OF 2019)
  • 5.9 COVID-19 IMPACT

6 FERTILITY TEST MARKET, BY PRODUCT

  • 6.1 INTRODUCTION
    • TABLE 11 FERTILITY TEST MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
  • 6.2 OVULATION PREDICTION KITS
    • 6.2.1 LOW COST AND EASY AVAILABILITY OF OVULATION PREDICTION KITS TO DRIVE THEIR ADOPTION
    • TABLE 12 OVULATION PREDICTION KITS MARKET, BY REGION, 2018-2025 (USD MILLION)
    • TABLE 13 OVULATION PREDICTION KITS MARKET, BY MODE OF PURCHASE, 2018-2025 (USD MILLION)
    • TABLE 14 OVULATION PREDICTION KITS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 15 OVULATION PREDICTION KITS MARKET, BY END USER, 2018-2025 (USD MILLION)
  • 6.3 FERTILITY MONITORS
    • TABLE 16 FERTILITY MONITORS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 17 FERTILITY MONITORS MARKET, BY REGION, 2018-2025 (USD MILLION)
    • TABLE 18 FERTILITY MONITORS MARKET, BY MODE OF PURCHASE, 2018-2025 (USD MILLION)
    • TABLE 19 FERTILITY MONITORS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 20 FERTILITY MONITORS MARKET, BY END USER, 2018-2025 (USD MILLION)
    • 6.3.1 URINE-BASED FERTILITY MONITORS
      • 6.3.1.1 Lower user-interpretation errors and fast and accurate results are advantages offered by urine-based monitors
    • TABLE 21 URINE-BASED FERTILITY MONITORS MARKET, BY REGION, 2018-2025 (USD MILLION)
    • TABLE 22 URINE-BASED FERTILITY MONITORS MARKET, BY MODE OF PURCHASE, 2018-2025 (USD MILLION)
    • TABLE 23 URINE-BASED FERTILITY MONITORS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 24 URINE-BASED FERTILITY MONITORS MARKET, BY END USER, 2018-2025 (USD MILLION)
    • 6.3.2 SALIVA-BASED FERTILITY MONITORS
      • 6.3.2.1 Saliva-based monitors offer cost-effectiveness and better hygiene
    • TABLE 25 SALIVA-BASED FERTILITY MONITORS MARKET, BY REGION, 2018-2025 (USD MILLION)
    • TABLE 26 SALIVA-BASED FERTILITY MONITORS MARKET, BY MODE OF PURCHASE, 2018-2025 (USD MILLION)
    • TABLE 27 SALIVA-BASED FERTILITY MONITORS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 28 SALIVA-BASED FERTILITY MONITORS MARKET, BY END USER, 2018-2025 (USD MILLION)
    • 6.3.3 BLOOD-BASED FERTILITY MONITORS
      • 6.3.3.1 Cost-effectiveness of blood-based monitors is expected to drive their adoption
    • TABLE 29 BLOOD-BASED FERTILITY MONITORS MARKET, BY REGION, 2018-2025 (USD MILLION)
    • TABLE 30 BLOOD-BASED FERTILITY MONITORS MARKET, BY MODE OF PURCHASE, 2018-2025 (USD MILLION)
    • TABLE 31 BLOOD-BASED FERTILITY MONITORS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 32 BLOOD-BASED FERTILITY MONITORS MARKET, BY END USER, 2018-2025 (USD MILLION)
    • 6.3.4 OTHER FERTILITY MONITORS
    • TABLE 33 OTHER FERTILITY MONITORS MARKET, BY REGION, 2018-2025 (USD MILLION)
    • TABLE 34 OTHER FERTILITY MONITORS MARKET, BY MODE OF PURCHASE, 2018-2025 (USD MILLION)
    • TABLE 35 OTHER FERTILITY MONITORS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 36 OTHER FERTILITY MONITORS MARKET, BY END USER, 2018-2025 (USD MILLION)
  • 6.4 MALE FERTILITY TESTING PRODUCTS
    • 6.4.1 MALE FERTILITY TESTING PRODUCTS TO ACCOUNT FOR THE LOWEST SHARE OF THE MARKET
    • TABLE 37 MALE FERTILITY TESTING PRODUCTS MARKET, BY REGION, 2018-2025 (USD MILLION)
    • TABLE 38 MALE FERTILITY TESTING PRODUCTS MARKET, BY MODE OF PURCHASE, 2018-2025 (USD MILLION)
    • TABLE 39 MALE FERTILITY TESTING PRODUCTS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 40 MALE FERTILITY TESTING PRODUCTS MARKET, BY END USER, 2018-2025 (USD MILLION)

7 FERTILITY TEST MARKET, BY MODE OF PURCHASE

  • 7.1 INTRODUCTION
    • TABLE 41 FERTILITY TEST MARKET, BY MODE OF PURCHASE, 2018-2025 (USD MILLION)
  • 7.2 DIRECT/PRESCRIPTION PRODUCTS
    • 7.2.1 AVAILABILITY OF INSURANCE COVERAGE FOR PRESCRIPTION REFILLS WILL DRIVE THE GROWTH OF THIS SEGMENT
    • TABLE 42 DIRECT/PRESCRIPTION PRODUCTS MARKET, BY REGION, 2018-2025 (USD MILLION)
  • 7.3 OTC PRODUCTS
    • 7.3.1 TREND OF SELF-MONITORING AND REMOTE ACCESS WILL BOOST THE GROWTH OF THIS SEGMENT
    • TABLE 43 OTC PRODUCTS MARKET, BY REGION, 2018-2025 (USD MILLION)
  • 7.4 ONLINE PRODUCTS
    • 7.4.1 INCREASING NUMBER OF E-PHARMACY PLATFORMS BOOSTING THE GROWTH OF THIS SEGMENT
    • TABLE 44 ONLINE PRODUCTS MARKET, BY REGION, 2018-2025 (USD MILLION)

8 FERTILITY TEST MARKET, BY APPLICATION

  • 8.1 INTRODUCTION
    • TABLE 45 FERTILITY TEST MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
  • 8.2 FEMALE FERTILITY TESTING
    • 8.2.1 RISING PREVALENCE OF PCOD/PCOS WILL BOOST THE GROWTH OF THIS SEGMENT
    • TABLE 46 GLOBAL BURDEN OF PCOS, 2019 (PER MILLION)
    • TABLE 47 FERTILITY TEST MARKET FOR FEMALE FERTILITY TESTING APPLICATIONS, BY REGION, 2018-2025 (USD MILLION)
  • 8.3 MALE FERTILITY TESTING
    • 8.3.1 GROWING ADOPTION OF ADVANCED FERTILITY DEVICES TO AID THE GROWTH OF THIS SEGMENT
    • TABLE 48 FERTILITY TEST MARKET FOR MALE FERTILITY TESTING APPLICATIONS, BY REGION, 2018-2025 (USD MILLION)

9 FERTILITY TEST MARKET, BY END USER

  • 9.1 INTRODUCTION
    • TABLE 49 FERTILITY TEST MARKET, BY END USER, 2018-2025 (USD MILLION)
  • 9.2 HOME CARE SETTINGS
    • 9.2.1 EASY ACCESS TO FERTILITY TESTING PRODUCTS THROUGH E-COMMERCE WEBSITES WILL STIMULATE THE GROWTH OF THIS SEGMENT
    • TABLE 50 FERTILITY TEST MARKET FOR HOME CARE SETTINGS, BY REGION, 2018-2025 (USD MILLION)
  • 9.3 HOSPITALS AND FERTILITY CENTERS
    • 9.3.1 INCREASING NUMBER OF FERTILITY CENTERS TO BOOST THE GROWTH OF THIS SEGMENT
    • TABLE 51 FERTILITY TEST MARKET FOR HOSPITALS AND FERTILITY CENTERS, BY REGION, 2018-2025 (USD MILLION)
  • 9.4 OTHER END USERS
    • TABLE 52 FERTILITY TEST MARKET FOR OTHER END USERS, BY REGION, 2018-2025 (USD MILLION)

10 FERTILITY TEST MARKET, BY REGION

  • 10.1 INTRODUCTION
    • TABLE 53 FERTILITY TEST MARKET, BY REGION, 2018-2025 (USD MILLION)
  • 10.2 NORTH AMERICA
    • FIGURE 29 NORTH AMERICA: FERTILITY TEST MARKET SNAPSHOT
    • TABLE 54 NORTH AMERICA: FERTILITY TEST MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 55 NORTH AMERICA: FERTILITY TEST MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
    • TABLE 56 NORTH AMERICA: FERTILITY MONITORS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 57 NORTH AMERICA: FERTILITY TEST MARKET, BY MODE OF PURCHASE, 2018-2025 (USD MILLION)
    • TABLE 58 NORTH AMERICA: FERTILITY TEST MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 59 NORTH AMERICA: FERTILITY TEST MARKET, BY END USER, 2018-2025 (USD MILLION)
    • 10.2.1 US
      • 10.2.1.1 High incidence of PCOD/PCOS will boost the growth of this market
    • TABLE 60 US: FERTILITY TEST MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
    • TABLE 61 US: FERTILITY MONITORS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • 10.2.2 CANADA
      • 10.2.2.1 Decreasing fertility rate and the increasing mean age of first-time pregnancies driving the market
    • TABLE 62 CANADA: FERTILITY TEST MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
    • TABLE 63 CANADA: FERTILITY MONITORS MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • 10.3 EUROPE
    • TABLE 64 EUROPE: FERTILITY TEST MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 65 EUROPE: FERTILITY TEST MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
    • TABLE 66 EUROPE: FERTILITY MONITORS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 67 EUROPE: FERTILITY TEST MARKET, BY MODE OF PURCHASE, 2018-2025 (USD MILLION)
    • TABLE 68 EUROPE: FERTILITY TEST MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 69 EUROPE: FERTILITY TEST MARKET, BY END USER, 2018-2025 (USD MILLION)
    • 10.3.1 GERMANY
      • 10.3.1.1 Increasing fertility concerns and awareness to drive market growth in Germany
    • TABLE 70 GERMANY: FERTILITY TEST MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
    • TABLE 71 GERMANY: FERTILITY MONITORS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • 10.3.2 UK
      • 10.3.2.1 Government initiatives and promotion of lab-based testing will stimulate market growth
    • TABLE 72 UK: FERTILITY TEST MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
    • TABLE 73 UK: FERTILITY MONITORS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • 10.3.3 FRANCE
      • 10.3.3.1 Increasing reforms for the management of POC tests to drive market growth in France
    • TABLE 74 FRANCE: FERTILITY TEST MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
    • TABLE 75 FRANCE: FERTILITY MONITORS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • 10.3.4 ITALY
      • 10.3.4.1 Decreasing fertility rates to drive the adoption of fertility testing devices in Italy
    • TABLE 76 ITALY: FERTILITY TEST MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
    • TABLE 77 ITALY: FERTILITY MONITORS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • 10.3.5 SPAIN
      • 10.3.5.1 Growing awareness of fertility testing products among women to drive market growth
    • TABLE 78 SPAIN: FERTILITY TEST MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
    • TABLE 79 SPAIN: FERTILITY MONITORS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • 10.3.6 REST OF EUROPE
    • TABLE 80 ROE: FERTILITY TEST MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
    • TABLE 81 ROE: FERTILITY MONITORS MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • 10.4 ASIA PACIFIC
    • FIGURE 30 ASIA PACIFIC: FERTILITY TEST MARKET SNAPSHOT
    • TABLE 82 ASIA PACIFIC: FERTILITY TEST MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 83 ASIA PACIFIC: FERTILITY TEST MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
    • TABLE 84 ASIA PACIFIC: FERTILITY MONITORS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 85 ASIA PACIFIC: FERTILITY TEST MARKET, BY MODE OF PURCHASE, 2018-2025 (USD MILLION)
    • TABLE 86 ASIA PACIFIC: FERTILITY TEST MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 87 ASIA PACIFIC: FERTILITY TEST MARKET, BY END USER, 2018-2025 (USD MILLION)
    • 10.4.1 JAPAN
      • 10.4.1.1 Increasing average age of first-time pregnancies to drive market growth
    • TABLE 88 JAPAN: FERTILITY TEST MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
    • TABLE 89 JAPAN: FERTILITY MONITORS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • 10.4.2 CHINA
      • 10.4.2.1 China dominated the Asia Pacific fertility test market in 2020
    • TABLE 90 CHINA: FERTILITY TEST MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
    • TABLE 91 CHINA: FERTILITY MONITORS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • 10.4.3 INDIA
      • 10.4.3.1 Increasing prevalence of PCOD/PCOS to drive market growth in India
    • TABLE 92 INDIA: FERTILITY TEST MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
    • TABLE 93 INDIA: FERTILITY MONITORS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • 10.4.4 AUSTRALIA
      • 10.4.4.1 Supportive government initiatives and rising investments to drive market growth
    • TABLE 94 AUSTRALIA: FERTILITY TEST MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
    • TABLE 95 AUSTRALIA: FERTILITY MONITORS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • 10.4.5 SOUTH KOREA
      • 10.4.5.1 Supportive government initiatives expected to positively impact market growth
    • TABLE 96 SOUTH KOREA: FERTILITY TEST MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
    • TABLE 97 SOUTH KOREA: FERTILITY MONITORS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • 10.4.6 REST OF ASIA PACIFIC
    • TABLE 98 ROAPAC: FERTILITY TEST MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
    • TABLE 99 ROAPAC: FERTILITY MONITORS MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • 10.5 LATIN AMERICA
    • TABLE 100 LATAM: FERTILITY TEST MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 101 LATAM: FERTILITY TEST MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
    • TABLE 102 LATAM: FERTILITY MONITORS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 103 LATAM: FERTILITY TEST MARKET, BY MODE OF PURCHASE, 2018-2025 (USD MILLION)
    • TABLE 104 LATAM: FERTILITY TEST MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 105 LATAM: FERTILITY TEST MARKET, BY END USER, 2018-2025 (USD MILLION)
    • 10.5.1 BRAZIL
      • 10.5.1.1 Shrinking population concerns will drive market growth
    • TABLE 106 BRAZIL: FERTILITY TEST MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
    • TABLE 107 BRAZIL: FERTILITY MONITORS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • 10.5.2 MEXICO
      • 10.5.2.1 Increasing population to drive market growth in Mexico
    • TABLE 108 MEXICO: FERTILITY TEST MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
    • TABLE 109 MEXICO: FERTILITY MONITORS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • 10.5.3 REST OF LATIN AMERICA
    • TABLE 110 ROLATAM: FERTILITY TEST MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
    • TABLE 111 ROLATAM: FERTILITY MONITORS MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • 10.6 MIDDLE EAST & AFRICA
    • 10.6.1 UNFAVORABLE REIMBURSEMENT POLICIES ARE EXPECTED TO RESTRAIN MARKET GROWTH IN MEA
    • TABLE 112 MEA: FERTILITY TEST MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
    • TABLE 113 MEA: FERTILITY MONITORS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 114 MEA: FERTILITY TEST MARKET, BY MODE OF PURCHASE, 2018-2025 (USD MILLION)
    • TABLE 115 MEA: FERTILITY TEST MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 116 MEA: FERTILITY TEST MARKET, BY END USER, 2018-2025 (USD MILLION)

11 COMPETITIVE LANDSCAPE

  • 11.1 OVERVIEW
  • 11.2 KEY STRATEGIES
  • 11.3 GLOBAL MARKET SHARE ANALYSIS (2019)
    • TABLE 117 FERTILITY TEST MARKET: DEGREE OF COMPETITION
    • FIGURE 31 SWISS PRECISION DIAGNOSTICS HELD THE LEADING POSITION IN THE FERTILITY TEST MARKET IN 2020
  • 11.4 COMPETITIVE LEADERSHIP MAPPING
  • 11.5 VENDOR INCLUSION CRITERIA
    • 11.5.1 STARS
    • 11.5.2 EMERGING LEADERS
    • 11.5.3 PERVASIVE PLAYERS
    • 11.5.4 PARTICIPANTS
    • FIGURE 32 FERTILITY TEST MARKET: GLOBAL COMPETITIVE LEADERSHIP MAPPING, 2019
  • 11.6 COMPETITIVE LEADERSHIP MAPPING: EMERGING COMPANIES/SMES/ START-UPS (2019)
    • 11.6.1 PROGRESSIVE COMPANIES
    • 11.6.2 STARTING BLOCKS
    • 11.6.3 RESPONSIVE COMPANIES
    • 11.6.4 DYNAMIC COMPANIES
    • FIGURE 33 FERTILITY TEST MARKET: GLOBAL COMPETITIVE LEADERSHIP MAPPING, 2019 (SME/START-UPS)
  • 11.7 COMPANY PRODUCT FOOTPRINT ANALYSIS
    • TABLE 118 PRODUCT FOOTPRINT OF COMPANIES
    • TABLE 119 APPLICATION FOOTPRINT OF COMPANIES
    • TABLE 120 REGIONAL FOOTPRINT OF COMPANIES
  • 11.8 COMPETITIVE SCENARIO
    • 11.8.1 PRODUCT LAUNCHES, ENHANCEMENTS, AND APPROVALS
    • TABLE 121 FERTILITY TEST MARKET: PRODUCT LAUNCHES, ENHANCEMENTS, AND APPROVALS, 2017-2020
    • 11.8.2 EXPANSIONS
    • TABLE 122 FERTILITY TEST MARKET: EXPANSIONS, 2017-2020
    • 11.8.3 OTHER STRATEGIES
    • TABLE 123 FERTILITY TEST MARKET: OTHER STRATEGIES, 2017-2020

12 COMPANY PROFILES

  • 12.1 KEY PLAYERS
  • (Business overview, Products offered, Recent Developments, SWOT analysis, MNM view)**
    • 12.1.1 SWISS PRECISION DIAGNOSTICS
    • TABLE 124 SWISS PRECISION DIAGNOSTICS: BUSINESS OVERVIEW
    • TABLE 125 SWISS PRECISION DIAGNOSTICS: PRODUCTS OFFERED
    • TABLE 126 FERTILITY TEST MARKET: PRODUCT LAUNCHES, JANUARY 2017 TO DECEMBER 2020
    • 12.1.2 CHURCH & DWIGHT
    • TABLE 127 CHURCH & DWIGHT: BUSINESS OVERVIEW
    • FIGURE 34 CHURCH & DWIGHT: COMPANY SNAPSHOT (2020)
    • TABLE 128 CHURCH & DWIGHT: PRODUCTS OFFERED
    • 12.1.3 PRESTIGE BRANDS HOLDINGS
    • TABLE 129 PRESTIGE BRANDS HOLDINGS: BUSINESS OVERVIEW
    • TABLE 130 PRESTIGE BRANDS HOLDINGS: PRODUCTS OFFERED
    • TABLE 131 FERTILITY TESTS MARKET: DEALS, JANUARY 2017 TO DECEMBER 2020
    • 12.1.4 BIOZHENA
    • TABLE 132 BIOZHENA: BUSINESS OVERVIEW
    • TABLE 133 BIOZHENA: PRODUCTS OFFERED
    • 12.1.5 FAIRHAVEN HEALTH
    • TABLE 134 FAIRHAVEN HEALTH: BUSINESS OVERVIEW
    • TABLE 135 FAIRHAVEN HEALTH: PRODUCTS OFFERED
    • 12.1.6 FERTILITY FOCUS
    • TABLE 136 FERTILITY FOCUS: BUSINESS OVERVIEW
    • TABLE 137 FERTILITY FOCUS: PRODUCTS OFFERED
    • TABLE 138 FERTILITY TEST MARKET: PRODUCT LAUNCHES, JANUARY 2016 TO DECEMBER 2020
    • TABLE 139 FERTILITY TEST MARKET: DEALS, JANUARY 2016 TO DECEMBER 2020
    • 12.1.7 GERATHERM MEDICAL
    • TABLE 140 GERATHERM MEDICAL: BUSINESS OVERVIEW
    • FIGURE 35 GERATHERM MEDICAL: COMPANY SNAPSHOT (2019)
    • TABLE 141 EXCHANGE RATES: EUR TO USD
    • TABLE 142 GERATHERM MEDICAL: PRODUCTS OFFERED
    • 12.1.8 HILIN LIFE PRODUCTS
    • TABLE 143 HILIN LIFE PRODUCTS: BUSINESS OVERVIEW
    • TABLE 144 HILIN LIFE PRODUCTS: PRODUCTS OFFERED
    • 12.1.9 UEBE MEDICAL
    • TABLE 145 UEBE MEDICAL: BUSINESS OVERVIEW
    • TABLE 146 UEBE MEDICAL: PRODUCTS OFFERED
    • 12.1.10 ADVACARE PHARMA
    • TABLE 147 ADVACARE PHARMA: BUSINESS OVERVIEW
    • TABLE 148 ADVACARE PHARMA: PRODUCTS OFFERED
    • 12.1.11 AVA
    • TABLE 149 AVA: BUSINESS OVERVIEW
    • TABLE 150 AVA: PRODUCTS OFFERED
    • TABLE 151 FERTILITY TEST MARKET: PRODUCT LAUNCHES, JANUARY 2017 TO DECEMBER 2020
    • TABLE 152 FERTILITY TEST MARKET: DEALS, JANUARY 2017 TO DECEMBER 2020
    • 12.1.12 BABYSTART (SNOWDEN HEALTHCARE)
    • TABLE 153 BABYSTART: BUSINESS OVERVIEW
    • TABLE 154 BABYSTART: PRODUCTS OFFERED
    • 12.1.13 VALLEY ELECTRONICS
    • TABLE 155 VALLEY ELECTRONICS: BUSINESS OVERVIEW
    • TABLE 156 VALLEY ELECTRONICS: PRODUCTS OFFERED
    • 12.1.14 SENSIIA
    • TABLE 157 SENSIIA: BUSINESS OVERVIEW
    • TABLE 158 SENSIIA: PRODUCTS OFFERED
    • TABLE 159 FERTILITY TEST MARKET: DEALS, JANUARY 2017 TO DECEMBER 2020
    • 12.1.15 MIRA CARE
    • TABLE 160 MIRA CARE: BUSINESS OVERVIEW
    • TABLE 161 MIRA CARE: PRODUCTS OFFERED
  • *Details on Business overview, Products offered, Recent Developments, SWOT analysis, MNM view might not be captured in case of unlisted companies.
  • 12.2 OTHER COMPANIES
    • 12.2.1 EXSEED HEALTH
    • 12.2.2 TEMPDROP
    • 12.2.3 PREGMATE
    • 12.2.4 MEDICAL ELECTRONIC SYSTEMS
    • 12.2.5 SWIM COUNT (SUBSIDIARY OF MOTILTYCOUNT APS)

13 APPENDIX

  • 13.1 DISCUSSION GUIDE
  • 13.2 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 13.3 AVAILABLE CUSTOMIZATIONS
  • 13.4 RELATED REPORTS
  • 13.5 AUTHOR DETAILS
Back to Top